The
global single
cell analysis market size is expected to reach USD 5.9 billion by
2025, according to a new report by Grand View Research, Inc. It is projected to
expand at a CAGR of 17.3% during the forecast period. High demand for early
detection techniques and rapid technological advancements are creating a
significant demand for single cell analysis. This technique is used in genomic,
transcriptomic, proteomics, and epigenetic studies.
Single
cell analytics helps assess cellular heterogeneity and aids in analysis of
pathways and processes at a molecular level. It can be performed with samples
as small as a single cell. Its current applications in diagnostics include
genetic analysis, prenatal screening, cancer genomics, and neurological
therapeutics.
Rising
prevalence of chronic diseases is anticipated to drive demand for molecular
assay services, subsequently leading to the growth of this sector. Single cell
analysis plays an important role in risk management related to organ
transplants, cancer, heart failure, renal diseases, and infectious disease
testing by performing fast, accurate, and effective tests.
Browse full research report on Single Cell Analysis Market: www.grandviewresearch.com/industry-analysis/single-cell-analysis-market
Further
key findings from the study suggest:
- In 2016,
consumables accounted for the largest market share owing to rapid adoption
of beads and microplates, repeat purchase of reagents, and demand for
assay kits
- Automated
instruments lead the instruments segment, owing to their advantages over
manually operated variants
- Companies in
this market are implementing strategies such as mergers and acquisitions
to expand their product portfolio and to strengthen their position. The
partnership between Illumina, Inc. and Bio-Rad Laboratories, Inc. is an
example of strategies implemented by leading players
- Major players
in this market include, but are not limited to, Thermo Fisher Scientific,
Inc.; Illumina, Inc.; Qiagen N.V.; Bio-Rad Laboratories, Inc.; Merck
Millipore GmbH; Beckman Coulter, Inc. (U.S.); and Becton, Dickinson and
Company (U.S.).
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/plastics-polymers-and-resins
Grand
View Research has segmented the global single cell analysis market on the basis
of product, application, and region:
Single
Cell Analysis Product Type Outlook (Revenue, USD Million, 2014 - 2025)
- Consumables
- Reagents
- Assay Kits
- Other
Consumables
- Instruments
- Manual
Instruments
- Microscopes
- Haemocytometers
- Automated
Instruments
- Flowcytometers
- Next
Generation Sequencing
- PCR Systems
- High-content
Screening System
- Cell
Microarrays
- Automated
Cell Counters
Single
Cell Analysis Application Type Outlook (Revenue, USD Million, 2014 - 2025)
- Cancer
- Immunology
- Neurology
- Stem Cell
- Non-invasive
Prenatal Diagnosis
- In-vitro
Fertilization
Single
Cell Analysis Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Latin America
- Mexico
- Brazil
- Middle East
& Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment